<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00306579</url>
  </required_header>
  <id_info>
    <org_study_id>054B26A43722225</org_study_id>
    <nct_id>NCT00306579</nct_id>
  </id_info>
  <brief_title>Myocardial Damage In Patients With Cerebral Infarction</brief_title>
  <official_title>Myocardial Damage In Patients With Cerebral Infarction. Prevalence and Characteristics as Measured by Troponins, Electrocardiographic Changes and Myocardial Perfusion Imaging.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danish Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fonden for Lægevidenskabelig Forskning for Fyns Amt.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>AJ Andersen og Hustrus Fond</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Overlægerådet Legatudvalg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Raimond and Dagmar Ringgård-Bohn's Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bankdirektør Hans Stener og hustru Agnes Steners legat</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Danish Heart Foundation</source>
  <brief_summary>
    <textblock>
      Introduction

      For several years &quot;ischemic&quot; electrocardiographic (ECG) changes in the acute phase of
      ischemic stroke have been reported. Whether these ECG changes reflect true myocardial
      ischemia remains controversial. So far no study has assessed different markers of myocardial
      ischemia or necrosis in consecutive patients admitted to hospital with an acute ischemic
      stroke.

      Purpose

      The main purpose of this study is to determine the potential burden of reversible and
      irreversible myocardial ischemia in patients with an acute ischemic stroke.

      Patients and methods

      Serial blood samples for measuring troponin T, CK-MB and NT-proBNP are collected in 250
      patients with evidence of an acute ischemic stroke admitted to the Department of Neurology at
      Odense University Hospital. In addition resting 12-lead ECG recordings will be obtained on a
      daily basis, and a 24-hour ST-segment ambulatory monitoring will be performed once within the
      first week of hospitalisation. Finally, myocardial perfusion patterns during rest will be
      evaluated by means of a myocardial perfusion scintigraphy in patients with an elevated
      troponin T level.

      Six months later control measurements of troponin T, CK-MB and NT-proBNP and a 12-lead ECG
      will be obtained.

      Expectations

      The study will contribute with original observations in patients with acute ischemic stroke
      considering the following issues:

        1. The prevalence and characteristics of ECG changes suggestive of myocardial ischemia.

        2. The prevalence of transient ST-segment changes on ambulatory monitoring.

        3. The prevalence and degree of myocardial necrosis as judged from biochemical markers.

        4. The prevalence of reversible and irreversible perfusion defects on myocardial
           scintigraphy.

        5. The prevalence, size and patterns of NT-proBNP.

        6. Whether there is a change in ECG and biochemical markers over a 6-month follow-up
           period.

      The results may have clinical implications regarding early and late treatment as well as
      clinical follow-up of patients recovering from an episode of acute ischemic stroke.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2003</start_date>
  <completion_date>May 2005</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment>250</enrollment>
  <condition>Ischemic Stroke</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Acute ischemic stroke.

          2. Age ≥ 18 years old.

          3. Written, informed consent.

        Exclusion Criteria:

          1. Onset of stroke symptoms 8 to 21 days before admission.

          2. Transient ischemic attack.

          3. Intracerebral or subarachnoid haemorrhage.

          4. Previous myocardial infarction.

          5. Any pathological Q waves on the baseline ECG.

          6. Current atrial fibrillation.

          7. Unstable angina pectoris ≤ 3 weeks before admission.

          8. Systolic blood pressure ≤ 90 mmHg and symptoms.

          9. Resuscitation after cardiac arrest.

         10. Unwillingness to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jesper K. Jensen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, Odense University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hans Mickley, DMSci</last_name>
    <role>Study Director</role>
    <affiliation>Department of Cardiology, Odense University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Søren Bak, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Neurology, Odense University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Poul Flemming H. Carlsen, DMSci</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Nuclear Medicine, Odense University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Søren R. Kristensen, DMSci</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Clinical Chemistry, Aalborg Hospital</affiliation>
  </overall_official>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2006</study_first_submitted>
  <study_first_submitted_qc>March 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2006</study_first_posted>
  <last_update_submitted>August 7, 2017</last_update_submitted>
  <last_update_submitted_qc>August 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2017</last_update_posted>
  <keyword>Ischemic Stroke</keyword>
  <keyword>Myocardial ischemia</keyword>
  <keyword>Myocardial necrosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

